Skip to main content
. Author manuscript; available in PMC: 2017 Aug 31.
Published in final edited form as: Adv Drug Deliv Rev. 2017 Jun 10;113:177–200. doi: 10.1016/j.addr.2017.06.002

Table 3.

Major structures of nanodrugs: advantages and disadvantages for brain delivery

Nanostructure Advantages for Brain Disadvantages for Brain
Comparison with nano covalent conjugates
Liposome
  • Vesicles on one or more phospholipid bilayer with aqueous core

  • 50 nm – 5 μm

  • Can cross BBTB through interendothelial gaps

  • Can be functionalized for active transport across BBB

  • Targeted liposomes are shown to accumulate in tumor tissue over normal brain (reduced non-specific toxicity)

  • Can carry both hydrophilic and hydrophobic drugs

  • Inherently non-toxic structure

  • Simple to manufacture [5]

  • Can control physiochemical properties of size, surface charge, and functionalization [6]

  • Low stability

  • Poor reproducibility

  • Low drug loading capacity for insoluble drugs

  • Limited control over drug release

  • Difficult to sterilize

  • Immunogenicity [6]

  • Low circulation time [7]

Dendrimers
  • Highly branched structure, extending from central core

  • Branches are synthetic polymeric macromolecules

  • 10-100 nm [6]

  • Uniform size and shape for BBB crossing [6, 7]

  • Many locations for drug/ligand attachment

  • High drug loading

  • High stability [6]

  • Carry both hydrophilic and hydrophobic drugs

  • Complicated synthesis and formulation development

  • Toxicity with amino functional groups [6]

  • Core is difficult to access

  • Some rely on limited diffusion mechanisms, not ideal for BBB crossing [7]

Polymer-conjugates
  • Macromolecular structure, often linear

  • 2-25 nm [8]

  • Inherently water soluble

  • Versatility with many regions for moiety attachment

  • Great potential for combinatorial therapeutics

  • Easily functionalized and high drug loading capacity [9]

  • Interactions with self form stable structure [7]

  • Covalent bonds might be present for 100%

  • Conjugate complexity requires careful physical-chemical characterization [9]

  • Potential uncertainty with composition

Micelles
  • Consist of biodegradable and biocompatible amphiphilic block polymers

  • 10-100 nm [6]

  • Can carry both hydrophilic and hydrophobic drugs

  • Hydrophilic shell provides stability and long circulation time

  • Small size allows for escape of RES

  • Easy sterilization

  • Popular in siRNA delivery, useful in brain tumor treatment

  • Versatile by polymer block selection

  • Low stability and tend to dissociate

  • Potential premature drug release (particularly bad for brain delivery)

  • Immunogenicity

  • Formulation scale up methods not yet available [6]

Carbon Nanotubes
  • Tube formed of graphene sheet, either open or capped

  • Diameter: 1 nm, length: several micrometers

  • Can penetrate BBB like needle

  • Can be functionalized with moieties covalently or non-covalently [6]

  • Not inherently soluble

  • Generate toxicity and biosafety issues

  • Difficult for targetable moieties to be attached

  • Low reproducibility [6]

Gold Nanoparticles
  • Silica core coated with thin gold layer [10]

  • 1-200 nm [8]

  • Small enough to pass through brain microvasculature

  • Neutral surface charge, low toxicity, and tissue reactivity for BBB crossing

  • Can uniquely produce heat for therapeutic effect

  • Large surface for functionalization

  • Potential toxicity and immunogenicity

  • Unknown effect of functionalization on biodistribution

Magnetic Nanoparticles
  • Iron oxide core coated with material such as polysaccharide, polymer, lipid, or protein

  • 1-200 nm [8]

  • Applications in both brain tumor treatment and imaging

  • Can cross BBB favorably

  • Can be administered systemically and targeted by external magnetic field

  • Demonstrated uptake by malignant brain tumor cells

  • Aggregation and instability

  • Non-specific uptake by RES

  • Potential toxicity and immunogenicity